| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of the immune response and viral evolution during the acute phase of SIV infection
|
Horton, Helen
|
|
2002
|
20 |
15 |
p. 1927-1932
6 p.
|
artikel
|
| 2 |
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
|
Amara, Rama Rao
|
|
2002
|
20 |
15 |
p. 1949-1955
7 p.
|
artikel
|
| 3 |
Development of a DNA-MVA/HIVA vaccine for Kenya
|
Hanke, Tomáš
|
|
2002
|
20 |
15 |
p. 1995-1998
4 p.
|
artikel
|
| 4 |
Development of an oral prime–boost strategy to elicit broadly neutralizing antibodies against HIV-1
|
Devico, Anthony L
|
|
2002
|
20 |
15 |
p. 1968-1974
7 p.
|
artikel
|
| 5 |
Efficiency of a myogenic DNA vaccine is strictly dependent upon cellular localization of HIV-1 Pr55gag
|
Bojak, Alexandra
|
|
2002
|
20 |
15 |
p. 1980-1984
5 p.
|
artikel
|
| 6 |
Engineered Listeria monocytogenes as an AIDS vaccine
|
Lieberman, Judy
|
|
2002
|
20 |
15 |
p. 2007-2010
4 p.
|
artikel
|
| 7 |
Foreword
|
Liljeström, Peter
|
|
2002
|
20 |
15 |
p. 1895-
1 p.
|
artikel
|
| 8 |
HIV and chemokines: Implications for therapy and vaccine
|
Lusso, Paolo
|
|
2002
|
20 |
15 |
p. 1964-1967
4 p.
|
artikel
|
| 9 |
HIV and lymphocyte dynamics
|
|
|
2002
|
20 |
15 |
p. 1933-
1 p.
|
artikel
|
| 10 |
HIV subtypes and recombination strains-strategies for induction of immune responses in man
|
Wahren, B
|
|
2002
|
20 |
15 |
p. 1988-1993
6 p.
|
artikel
|
| 11 |
HIV T cell vaccines, the importance of clades
|
McMichael, Andrew
|
|
2002
|
20 |
15 |
p. 1918-1921
4 p.
|
artikel
|
| 12 |
HIV vaccine evaluation center in Rio de Janeiro, Brazil
|
Schechter, Mauro
|
|
2002
|
20 |
15 |
p. 1909-1911
3 p.
|
artikel
|
| 13 |
HIV vaccines: the Uganda experience
|
Mugyenyi, Peter N
|
|
2002
|
20 |
15 |
p. 1905-1908
4 p.
|
artikel
|
| 14 |
HIV vaccine strategies
|
Nabel, Gary J
|
|
2002
|
20 |
15 |
p. 1945-1947
3 p.
|
artikel
|
| 15 |
Immunity, immunopathology and vaccines against HIV?
|
Zinkernagel, Rolf M
|
|
2002
|
20 |
15 |
p. 1913-1917
5 p.
|
artikel
|
| 16 |
Innate T cell immunity to HIV-infection
|
Gougeon, M.L
|
|
2002
|
20 |
15 |
p. 1938-1941
4 p.
|
artikel
|
| 17 |
Issues for improving multiplasmid DNA vaccines for HIV-1
|
Muthumani, Karuppiah
|
|
2002
|
20 |
15 |
p. 1999-2003
5 p.
|
artikel
|
| 18 |
Mechanisms of protection against simian immunodeficiency virus infection
|
Johnson, R.Paul
|
|
2002
|
20 |
15 |
p. 1985-1987
3 p.
|
artikel
|
| 19 |
Muscle specific versus ubiquitous expression of Gag based HIV-1 DNA vaccines: a comparative analysis
|
Bojak, Alexandra
|
|
2002
|
20 |
15 |
p. 1975-1979
5 p.
|
artikel
|
| 20 |
Passive immunization with human neutralizing monoclonal antibodies: correlates of protective immunity against HIV
|
Xu, Weidong
|
|
2002
|
20 |
15 |
p. 1956-1960
5 p.
|
artikel
|
| 21 |
Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1
|
Mascola, John R
|
|
2002
|
20 |
15 |
p. 1922-1925
4 p.
|
artikel
|
| 22 |
Past, present and future of HIV vaccine trials in developing countries
|
Esparza, José
|
|
2002
|
20 |
15 |
p. 1897-1898
2 p.
|
artikel
|
| 23 |
Politics, the media and science in HIV/AIDS: the peril of pseudoscience
|
Makgoba, M.W.
|
|
2002
|
20 |
15 |
p. 1899-1904
6 p.
|
artikel
|
| 24 |
The advantage of early recognition of HIV-infected cells by cytotoxic T-lymphocytes
|
Gruters, Rob A
|
|
2002
|
20 |
15 |
p. 2011-2015
5 p.
|
artikel
|
| 25 |
The critical role of CD4+ T-cell help in immunity to HIV
|
Heeney, Jonathan Luke
|
|
2002
|
20 |
15 |
p. 1961-1963
3 p.
|
artikel
|
| 26 |
Therapeutic vaccination in primary HIV infection, the Quest 1 Quest Core Group and Research Team: D. Cooper, Australia; B. Hoen, France; S. Kinloch, UK; A. Phillips, UK; C. Tsoukas, Canada; J. Andersson, Sweden; F. Lampe, UK; B. Autran, France; G. Janossy, UK; V. Miller, Germany; Z. Racz, Germany; R. Sekaly, Canada; clinicians in more than 20 recruiting centres and the supporting team of GlaxoSmithKline: V. Mallet, S. Turkish, S. Fortes, C. Python, M. Haberl and Li-Ean Goh, Quest project leader UK. Industry collaborators—main sponsor: GlaxoSmithKline, Hugh Mc Dade; Roche Molecular Systems: B. Dale, A. Capt; Immune Response Corporation: R. Moss, J. Dively. 1 trial
|
Perrin, Luc
|
|
2002
|
20 |
15 |
p. 2004-2006
3 p.
|
artikel
|
| 27 |
Toward 3rd World therapy and an HIV preventive vaccine
|
|
|
2002
|
20 |
15 |
p. 1942-1943
2 p.
|
artikel
|
| 28 |
Understanding the basis of CD4+ T-cell depletion in macaques infected by a simian–human immunodeficiency virus
|
Etemad-Moghadam, Bijan
|
|
2002
|
20 |
15 |
p. 1934-1937
4 p.
|
artikel
|
Tijdschrift beschrijving